CapsoVision, Inc (CV) shareholders
CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30383% above fair value
$6.03−0.24 (-3.83%)
Close on Nov 13, 2026Market cap $301.78MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
10.2%
5M of 50M shares
Institutional holders
50
6 new, 6 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
7 buys · 1 sales
Net bought $21.00M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Eliyahou Harari Joint filing with Britt Harari (11.50%), Harari Family Trust (6.30%) | 7,014,554 | 13.20% | 13G (passive) amendment | Sep 18, 2026 |
| Shen Ching Hang | 6,400,527 | 12.80% | 13G (passive) amendment | Apr 10, 2026 |
| Kioxia Corporation Joint filing with Kioxia Holdings Corporation (7.40%) | 3,446,925 | 7.40% | 13G (passive) | Jul 1, 2025 |
| Chih Cheng Chang Joint filing with CID Greater China Venture Capital Fund III, L.P. (6.70%), CID Venture Capital General Partner III, Limited (6.70%) and 2 more | 3,125,732 | 6.70% | 13G (passive) | Sep 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CV | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 1,896,088 | 3.79% | $14.37M | +591,667 | 0.00% |
| Vanguard Capital Management LLC | 1,058,468 | 2.11% | $8.02M | +32,199 | 0.00% |
| Geode Capital Management, LLC | 578,482 | 1.16% | $4.39M | +143,328 | 0.00% |
| State Street Corp | 410,241 | 0.82% | $3.11M | +154,200 | 0.00% |
| Vanguard Portfolio Management LLC | 240,425 | 0.48% | $1.82M | +76,039 | 0.00% |
| Northern Trust Corp | 220,095 | 0.44% | $1.67M | +67,761 | 0.00% |
| Vanguard Fiduciary Trust Co | 103,630 | 0.21% | $785.52K | +14,998 | 0.00% |
| Charles Schwab Investment Management Inc | 79,360 | 0.16% | $601.55K | +17,983 | 0.00% |
| Bank of New York Mellon Corp | 75,021 | 0.15% | $568.66K | +25,727 | 0.00% |
| Nuveen, LLC | 46,011 | 0.09% | $348.76K | +12,913 | 0.00% |
| Deutsche Bank AG\ | 34,700 | 0.07% | $263.03K | +9,411 | 0.00% |
| XTX Topco Ltd | 31,845 | 0.06% | $241.39K | −35,536 | 0.00% |
| Wells Fargo & Company/Mn | 31,820 | 0.06% | $241.20K | +21,575 | 0.00% |
| Price T Rowe Associates Inc /Md/ | 29,026 | 0.06% | $221.00K | +9,476 | 0.00% |
| Bank Of America Corp /De/ | 25,469 | 0.05% | $193.06K | +3,231 | 0.00% |
| Rhumbline Advisers | 21,969 | 0.04% | $166.52K | +8,837 | 0.00% |
| MetLife Investment Management, LLC | 21,114 | 0.04% | $160.04K | +4,408 | 0.00% |
| Invesco Ltd. | 18,827 | 0.04% | $142.71K | New | 0.00% |
| Morgan Stanley | 18,723 | 0.04% | $141.92K | +3,787 | 0.00% |
| Goldman Sachs Group Inc | 18,627 | 0.04% | $141.19K | −17,484 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 50 | 5M | 10.2% | 6 / 31 | 7 / 6 | 1M | 0M |
| Q1 2026 | 51 | 4M | 8.0% | 23 / 24 | 1 / 3 | 3M | 0M |
| Q4 2025 | 32 | 1M | 1.5% | 8 / 13 | 7 / 2 | 0M | 0M |
| Q3 2025 | 26 | 0M | 0.8% | 26 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
74 funds held CV in Q2 2026, 75% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of CV | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 925,200 | 1.85% | $7.01M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 825,385 | 1.65% | $6.26M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 381,157 | 0.76% | $2.51M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 315,596 | 0.63% | $2.39M | 0.02% | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 142,359 | 0.28% | $965.19K | 0.01% | May 31, 2026 |
| iShares Micro-Cap ETF | 114,619 | 0.23% | $868.81K | 0.06% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 100,983 | 0.20% | $765.45K | 0.00% | Jun 30, 2026 |
| Schwab Small-Cap Index Fund | 85,030 | 0.17% | $559.50K | 0.01% | Jul 31, 2026 |
| Master Small Cap Index Series | 62,155 | 0.12% | $471.13K | 0.01% | Jun 30, 2026 |
| Nuveen Small Cap Blend Index Fund | 46,011 | 0.09% | $302.75K | 0.01% | Jul 31, 2026 |
| EQ/2000 Managed Volatility Portfolio | 36,706 | 0.07% | $278.23K | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Growth Index Fund | 32,592 | 0.07% | $247.05K | 0.02% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 30,790 | 0.06% | $208.76K | 0.00% | May 31, 2026 |
| Fidelity Extended Market Index Fund | 29,810 | 0.06% | $202.11K | 0.00% | May 31, 2026 |
| LVIP State Street Small-Cap Index Fund | 25,800 | 0.05% | $195.56K | 0.01% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Kang-Huai Wang | See Remarks, Director | 721,732 | 1.44% | Jun 3, 2026 |
| Douglas Patrick Atkinson | Head of Global Sales | 107,357 | 0.21% | Jun 3, 2026 |
| David Michael Garcia | Sr. VP of Finance | – | – | Jun 3, 2026 |
| Rebecca Ann Petersen | Director of Clinical Affairs | 24,834 | 0.05% | Aug 22, 2025 |
| Kevin Michael Lundquist | Chief Financial Officer | – | – | Jul 1, 2025 |
| David Stanley Shields | Director | 0 | – | Jul 2, 2026 |
| Joanne Carol Imperial | Director | 1,687 | 0.00% | Jul 1, 2026 |
| Hui Ying Kuo | Director | 15,263 | 0.03% | Jul 1, 2026 |
| Julia S. Gouw | Director | 4,909 | 0.01% | Jul 1, 2026 |
| Wen-Herng Henry King | Director | 25,619 | 0.05% | Jul 1, 2026 |
| Michele Harari | Director | 61,065 | 0.12% | Jul 1, 2026 |
| Chen Lung Tsai | Director | 120,385 | 0.24% | Jul 1, 2026 |
| Ching Hang Shen | 10% owner | 6,400,527 | 12.79% | Sep 23, 2026 |
| Eliyahou Et Al Harari | 10% owner | 2,274,942 | 4.55% | Sep 23, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Eliyahou Et Al Harari 10% owner | Sep 18, 2026 | Buy | +878,735 | $5.69 | $5.00M | 1,396,494 |
| Eliyahou Et Al Harari 10% owner | Sep 18, 2026 | Buy | +878,734 | $5.69 | $5.00M | 878,734 |
| Ching Hang Shen 10% owner | Sep 15, 2026 | Buy | +878,734 | $5.69 | $5.00M | 7,279,261 |
| Ching Hang Shen 10% owner | Sep 15, 2026 | Buy | +878,734 | $5.69 | $5.00M | 2,926,655 |
| Eliyahou Et Al Harari 10% owner | Jul 17, 2026 | Buy | +61,068 | $6.73 | $410.99K | 3,343,119 |
| Eliyahou Et Al Harari 10% owner | Jul 8, 2026 | Buy | +81,300 | $6.09 | $495.12K | 3,282,051 |
| Chen Lung Tsai Director | Jun 30, 2026 | Option exercise | +2,022 | $7.58 | $15.33K | 4,929 |
| Michele Harari Director | Jun 30, 2026 | Option exercise | +2,022 | $7.58 | $15.33K | 61,065 |
| Joanne Carol Imperial Director | Jun 30, 2026 | Option exercise | +2,022 | $7.58 | $15.33K | 3,709 |
| Wen-Herng Henry King Director | Jun 30, 2026 | Option exercise | +2,022 | $7.58 | $15.33K | 25,619 |
| Julia S. Gouw Director | Jun 30, 2026 | Option exercise | +2,022 | $7.58 | $15.33K | 4,909 |
| Hui Ying Kuo Director | Jun 30, 2026 | Option exercise | +2,022 | $7.58 | $15.33K | 15,263 |
| Eliyahou Et Al Harari 10% owner | Jun 26, 2026 | Buy | +13,850 | $7.35 | $101.80K | 3,200,751 |
| Joanne Carol Imperial Director | Jun 8, 2026 | Sale | −1,200 | $7.16 | $8.59K | 1,687 |
| Douglas Patrick Atkinson Head of Global Sales | May 5, 2026 | Option exercise | +34,786 | $0.57 | $19.83K | 107,357 |
| Douglas Patrick Atkinson Head of Global Sales | May 4, 2026 | Option exercise | +30,030 | $0.37 | $11.11K | 66,066 |
| Douglas Patrick Atkinson Head of Global Sales | May 4, 2026 | Option exercise | +36,036 | $0.29 | $10.45K | 36,036 |
| Douglas Patrick Atkinson Head of Global Sales | May 4, 2026 | Option exercise | +6,505 | $0.57 | $3.71K | 72,571 |
| Ching Hang Shen 10% owner | Apr 17, 2026 | Other | −3,991,606 | – | – | 0 |
| Ching Hang Shen 10% owner | Apr 17, 2026 | Other | +3,991,606 | – | – | 6,400,527 |
| Wen-Herng Henry King Director | Dec 31, 2025 | Option exercise | +2,887 | $10.69 | $30.86K | 23,597 |
| Michele Harari Director | Dec 31, 2025 | Option exercise | +2,887 | $10.69 | $30.86K | 59,043 |
| Julia S. Gouw Director | Dec 31, 2025 | Option exercise | +2,887 | $10.69 | $30.86K | 2,887 |
| Joanne Carol Imperial Director | Dec 31, 2025 | Option exercise | +2,887 | $10.69 | $30.86K | 2,887 |
| Hui Ying Kuo Director | Dec 31, 2025 | Option exercise | +2,887 | $10.69 | $30.86K | 13,241 |
| Chen Lung Tsai Director | Dec 31, 2025 | Option exercise | +2,887 | $10.69 | $30.86K | 2,887 |
| Rebecca Ann Petersen Director of Clinical Affairs | Aug 18, 2025 | Option exercise | +24,834 | $0.37 | $9.19K | 24,834 |
| Chen Lung Tsai Director | Jul 3, 2025 | Buy | +20 | $4.17 | $83 | 20 |
| Eliyahou Et Al Harari 10% owner | Jul 3, 2025 | Conversion | +517,759 | – | – | 517,759 |
| Eliyahou Et Al Harari 10% owner | Jul 3, 2025 | Conversion | +517,759 | – | – | 517,759 |
| Eliyahou Et Al Harari 10% owner | Jul 3, 2025 | Conversion | +3,186,904 | – | – | 3,186,904 |
| Eliyahou Et Al Harari 10% owner | Jul 3, 2025 | Conversion | +3,186,904 | – | – | 3,186,904 |
| Eliyahou Et Al Harari 10% owner | Jul 3, 2025 | Conversion | +517,759 | – | – | 517,759 |
| Eliyahou Et Al Harari 10% owner | Jul 3, 2025 | Conversion | +517,759 | – | – | 517,759 |
| Wen-Herng Henry King Director | Jul 3, 2025 | Conversion | +20,710 | – | – | 20,710 |
| Hui Ying Kuo Director | Jul 3, 2025 | Conversion | +10,354 | – | – | 10,354 |
| Chen Lung Tsai Director | Jul 3, 2025 | Conversion | +91,432 | – | – | 115,456 |
| Kang-Huai Wang See Remarks, Director | Jul 3, 2025 | Conversion | +446,896 | – | – | 721,732 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
5.49%
2M shares short
Days to cover
14.3
At 0M shares a day
Change since last report
-10.6%
From 2M shares
Short volume, 20 days
77.7%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of CapsoVision's stock actually held short. Settlement fails (shares not delivered on time) peaked at 38,426 shares on Sep 24, 2026 over the last 90 days.
See a number that looks wrong?